Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma crawled date : 2022 - 09 - 06 save search
Cocrystal Pharma to Participate in the H.C. Wainwright Global Investment Conference
Published: 2022-09-06 (Crawled : 19:00) - biospace.com/
COCP | $1.43 -1.39% 5.1K
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: -5.84%
pharma global conference
MEI Pharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference 2022
Published: 2022-09-06 (Crawled : 14:00) - biospace.com/
MEIP | $3.38 2.11% 2.07% 12K
|
Health Technology
|
| O: 1.09%
H: 2.61%
C: -4.27%
pharma global conference
Athira Pharma Provides Update on Plans for Ongoing LIFT-AD Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Patients
Published: 2022-09-06 (Crawled : 13:00) - globenewswire.com
ATHA | $2.07 -1.9% -1.93% 200K
|
Health Technology
|
| O: 0.61%
H: 0.61%
C: -3.66%
ongoing pharma alzheimer’s update study fosgonimeton
Inozyme Pharma to Present at H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-06 (Crawled : 13:00) - globenewswire.com
INZY | $4.57 -1.72% -1.75% 560K
|
Health Technology
|
| O: -0.99%
H: 1.66%
C: -2.33%
pharma global conference
aTyr Pharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference 2022
Published: 2022-09-06 (Crawled : 13:00) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: -0.87%
H: 3.8%
C: 1.46%
pharma global conference
Ocuphire Pharma to Present at The H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-06 (Crawled : 13:00) - globenewswire.com
OCUP | $1.675 -3.74% -3.88% 240K
|
Health Technology
|
| O: 3.59%
H: 0.0%
C: -4.33%
pharma global conference
FDA and Health Canada Clear IND for FSD Pharma to Proceed with Phase 2 Trial of FSD201 for Nociplastic Pain Associated with Idiopathic Mast Cell Activation Syndrome
Published: 2022-09-06 (Crawled : 13:00) - biospace.com/
HUGE | $0.6167 1.22% 29K
|
Process Industries
|
| O: 0.28%
H: 1.96%
C: -1.3%
fsd201 fda pharma canada health trial phase 2
Evoke Pharma to Participate in H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-06 (Crawled : 13:00) - biospace.com/
EVOK | $0.489 -10.93% -12.27% 21K
|
Health Technology
|
| O: -0.39%
H: 0.07%
C: -4.3%
pharma global conference
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.